# A Clinical Study of MK-1045 in People With Lupus or Rheumatoid Arthritis (MK-1045-004)

> **NCT07363590** · PHASE1 · RECRUITING · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 21 (estimated)

## Conditions studied

- Systemic Lupus Erythematosus
- Rheumatoid Arthritis

## Interventions

- **BIOLOGICAL:** MK-1045

## Key facts

- **NCT ID:** NCT07363590
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-02-19
- **Primary completion:** 2029-07-16
- **Final completion:** 2029-07-16
- **Target enrollment:** 21 (ESTIMATED)
- **Last updated:** 2026-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07363590

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07363590, "A Clinical Study of MK-1045 in People With Lupus or Rheumatoid Arthritis (MK-1045-004)". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT07363590. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*